The present study explored the functional role of microRNA (miR)-194 in lipopolysaccharide (LPS) induced lung cell injury, along with the underlying mechanisms and to reveal the potential role in infantile pneumonia. Human fibroblasts WI38 cells were transfected with miR-194 mimic or miR-194 inhibitor, and the transfection efficiency was confirmed by quantitative realtime polymerase chain reaction (qRT-PCR). Thereafter, the cells were treated with or without LPS, and then cell viability, cell apoptosis and mRNA and protein expressions of key proteins of nuclear factor kappa B (NF-κB) pathway including inhibitor of NF-κB (IκB) α, p-65, and B-cell CLL/lymphoma (Bcl) 3 were analyzed. Results showed that overexpression and suppression of miR-194 was effective. Administration of LPS significantly decreased the cell viability and statistically promoted the percentages of apoptotic cells and increased the mRNA and protein expressions of p-65 and Bcl-3 but downregulated IκBα compared to the control group (P < 0.05 or P < 0.01). LPS in combination with miR-194 suppression further enhanced the effects of LPS on cell viability and cell apoptosis compared to the LPS group (P < 0.05). In contrast, LPS in combination with miR-194 overexpression observably reversed the effects of LPS on cell viability, cell apoptosis and mRNA and protein expressions of the key proteins (P < 0.05 or P < 0.01). In conclusion, miR-194 increases the LPS-induced the inhibition of cell viability and increasing of the cell apoptosis by inhibition of NF-κB pathway in WI38 cells. MiR-194 might be a potential targeted therapy for treatment of infantile pneumonia.
MicroRNA-194 Regulates

Introduction
Pneumonia carries a high risk of morbidity and mortality, especially among children, causing about 23% of mortality in infants [1, 2] . Infantile pneumonia has been ranked as one of the three most important forms of pneumonia by the World Health Organization (WHO), and it has been classified as one of four critical diseases in child health in China [3] . Approximately 4, 000, 000 children die each year due to pneumonia among < 5 years old worldwide, particularly in developing countries (300, 000 new deaths are observed in China every year) [3] . Bacterial infection, viral infection, and Mycoplasma pneumoniae infection are the three main causes of infantile pneumonia. Although significant advances have been made in recent years in the diagnosis and treatment of infantile pneumonia, this disease still threatens the health of many children. Thus, there is an urgent need to explore new potential targeted therapies for treatment of infantile pneumonia.
MicroRNAs (miRNAs) are small short endogenous RNAs that regulate the expression of complementary messenger RNAs (mRNAs) at the post-transcriptional level by mainly binding to the 3'-untranslated region (UTR) of target mRNAs [4, 5] . It has been well known that miRNAs play an important role in regulating various cell functions such as cell proliferation, differentiation, migration, invasion, and apoptosis [6] . A growing number of studies have confirmed that miRNAs are differentially expressed in pneumonia, and many of them have been considered as biomarkers of pneumonia [7] [8] [9] . Among the miRNAs, miR-194 has been widely studied in various cancer cells, and shows complicated functions in regulating cell differentiation [10] , cell migration [11] , cell proliferation, apoptosis [12] , and invasion [13] . For example, Dong et al. suggested that miR-194 inhibited epithelial to mesenchymal transition (EMT) of endometrial cancer (EC) cells by targeting oncogene B-cell-specific Moloney murine leukemia virus insertion site 1 (BMI-1) and inhibition of BMI-1 by miR-194 may have therapeutic potential in suppressing EC metastasis [14] . In addition, a previous study showed that miR-194 may serve as a valuable prognostic marker and promising interventional therapeutic target for hepatocellular carcinoma (HCC) [15] . Moreover, it has been reported that miR-194 plays a significant role in chondrogenic differentiation of human Adipose-derived stem cells (ASCs), which may provide a novel insight into cell manipulation methods during cartilage regeneration [16] . However, little information is available about the role of miR-194 in regulating lung cell injury, as well as its potential functional role in infantile pneumonia.
Therefore, in the present study, we aimed to explore the functional role of miR-194 in lung cell injury and potential role in infantile pneumonia. Human lung fibroblast WI38 cells were transfected with miR-194 mimic or inhibitor, and then the cells were stimulated with lipopolysaccharide (LPS) to induce lung cell injury and inflammatory response. Thereafter, the effects of miR-194 aberrant expression on cell viability and cell apoptosis were investigated. Moreover, we explored the involved potential signalling pathway. Our study might provide new insights into potential targeted therapies for treatment of infantile pneumonia.
Materials and Methods
Cell culture
Normal human fibroblasts WI38 cell line was obtained from the American Type Culture Collection (ATCC, Manassas, VA, USA). The cells were cultured in Dulbecco's modified Eagle's medium (DMEM; SigmaAldrich, St Louis, USA) supplemented with 10% fetal bovine serum (FBS; Gibco, Grand Island, NY, USA), 100 units antibiotic/antimycotic solution (Invitrogen, Carlsbad, CA, USA) and 50 µg/mL gentamycin (Invitrogen) with 1 mM Na pyruvate at 37°C in a humidified atmosphere with 5% CO 2 . 
Cell treatment and plasmid transfection
Cell viability
After incubation with LPS and/or transfection with miR-194 mimic or miR-194 inhibitor, the cell viability was analyzed by 3-(4, 5-dimethylthiazol-2-yl)-2 5-diphenyl-2Htetrazolium bromide (MTT) colorimetric assay according to a standardized method [17] . Briefly, the cells were seeded in 96-well plates and treated with LPS and/or transfected with miR-194 mimic or miR-194 inhibitor. After 1, 2, 3, and 4 days of treatment, 20 μL 5 mg/mL MTT (Invitrogen) was added to the plates and incubated at 37°C for 4 h. Thereafter, 100 μL dimethylsulfoxide (DMSO; Sigma-Aldrich) was added to dissolve the formazan crystals. Absorbance at 570 nm was read by a microplate reader (Bio-Rad Benchmark, Hercules, CA, USA). The data was graphed as relative cell viabilities [(OD570 drug)/ (OD570 virus control)] for each group.
Apoptosis assay
After incubation with LPS and/or transfection with miR-194 mimic or miR-194 inhibitor, the cell apoptosis was assessed by an Annexin V/ fluorescein isothiocynate (FITC) and propidium iodide (PI) apoptosis detection kit (BD Biosciences, Heidelberg, Germany) according to the manufacturer's criterions. Briefly, after treatment and transfection for 48 h, the cells were harvested and suspended in Annexin-binding buffer, and then were incubated with Annexin V-FITC and PI for 15 min in the dark at room temperature. The apoptotic percentages of cells were analyzed by flow cytometry using a FACScan cytometer (BD Biosciences, USA) and the data was analyzed with FlowJo software (Tree Star, Ashland, OR).
Western blot analysis
After incubation with LPS and/or transfection with miR-194 mimic, the cell suspension was collected, centrifuged, and lysed in a RIPA lysis buffer containing protease inhibitor. The proteins were quantified using the BCA™ Protein Assay Kit (Pierce, Rockford, IL). The protein samples were then subjected to a 10-12% sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis (PAGE) gels and transferred to polyvinylidene fluoride (PVDF) membranes. After washing with phosphate buffer saline (PBS), the membranes were then blocked with 5% skim milk in Tris Buffered Saline with Tween (TBST) for 1 h. Subsequently, the membranes were incubated with the following primary antibodies overnight at 4°C: anti-IκBα antibody (rabbit mAb #4812; Cell Signaling Technology, Beverly, MA, USA); anti-phospho-IκBα (p-IκBα) antibody (rabbit mAb #5209; Cell Signaling Technology); anti-p65 antibody (rabbit mAb #8242; Cell Signaling Technology); anti-phospho-p65 (p-p65) antibody (rabbit mAb #3033; Cell Signaling Technology); and anti-B-cell CLL/lymphoma 3 (Bcl-3) antibody (rabbit mAb ab137499, Abcam, Cambridge, UK). The membranes were then washed three times with TBST and incubated with horseradish peroxidase (HRP)-conjugated secondary antibodies (Abcam) for 2 h. WEST-ZOL-plus Western Blot Detection System (Intron Biotechnology, Inc., Korea) was used to detect the protein bands. Probing for GAPDH (Abcam) was used as a loading control.
Results
Transfection efficiency of miR-194
qRT-PCR was performed to confirm the transfection efficiency. As shown in Fig. 1A , the expression levels of miR-194 were significantly increased by transfection with miR-194 mimic compared to the control group (P < 0.01), and were statistically decreased by transfection with miR-194 inhibitor (P < 0.05). The results demonstrated that the transfection efficiency was apparent and could be used for further analysis.
Effects of miR-194 aberrant expression on cell viability
After abnormal expression of miR-194, we analyzed the effects of miR-194 aberrant expression on cell viability. The cell viability was determined by MTT. As shown in Fig.  1B , the results revealed that the cell viability was greatly lowered by LPS compared to the control group after 3 and 4 days of treatment (both P < 0.01). No significant differences were found in the cell viability after 1 and 2 days of treatment. In addition, we observed that LPS combined with overexpression of miR-194 prominently elevated the cell viability compared to the LPS group after 3 and 4 days of treatment (P < 0.05 or P < 0.01), and while suppression of miR-194 remarkably downregulated the cell viability compared to the LPS group after 3 and 4 days of treatment (both P < 0.05). The results indicated that overexpression of miR-194 could significantly promote the cell viability.
Effects of miR-194 aberrant expression on cell apoptosis
Moreover, the effects of miR-194 aberrant expression on the cell apoptosis were analyzed by flow cytometry. As shown in Fig. 2A and 2B, we found that compared to the control group, the percentages of apoptotic cells were remarkably promoted by LPS (P < 0.05). However, the percentages of apoptotic cells were strikingly downregulated by overexpression of miR-194 compared to the LPS group (P < 0.05), and while were distinctly increased by suppression of miR-194 (P < 0.05). These data suggested that overexpression of miR-194 could statistically inhibit the cell apoptosis. 
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Effects of miR-194 overexpression on the NF-κB pathway key proteins expression
To further understand the underlying mechanism, both mRNA and protein expressions of NF-κB pathway key proteins, IκBα, p-IκBα, p-65, p-p65, and Bcl-3, were measured after miR-194 aberrant expression and/or treatment with LPS. Non-treated cells were considered as the control group. As indicated in Fig. 3A , the data showed that the mRNA expression levels of p/t-p65 and Bcl-3 were all significantly raised but the levels of p/t-IκBα were lowered by LPS compared to the control group (P < 0.05). Moreover, LPS combined with overexpression of miR-194 statistically reversed the effects of LPS (P < 0.05), while on the other hand, miR-194 overexpression alone further statistically increased the mRNA levels of p/t-IκBα but decreased levels of p/t-p65 and Bcl-3 compared to the LPS group (P < 0.01). Similar results were observed in the protein levels (Fig. 3B) . Our results indicated that overexpression of miR-194 could inhibit the NF-κB pathway.
Discussion
In the present study, the results showed that LPS significantly downregulated the cell viability, upregulated the percentages of apoptotic cells, increased the mRNA and protein expressions of p-65 and Bcl-3 but decreased expression of IκBα. Overexpression of miR-194 significantly attenuated the effects of LPS on cell viability, cell apoptosis, and the mRNA and protein expressions of IκBα, p-65, and Bcl-3. However, suppression of miR-194 further enhanced the effects of LPS on cell viability and cell apoptosis. Our study indicated that miR-194 might be a protective factor in LPS-induced lung injury and overexpression of miR-194 might be a potential targeted therapy for treatment of infantile pneumonia.
The functional role of miR-194 has been studied for a long time; however, most studies have been focused on its biological functions in various tumour cells. Emerging studies suggest that miR-194 is considered as a tumour suppressor and its targets were identified in many cells and tissues. For example, Han et al. demonstrated that overexpression of miR-194 significantly repressed the proliferation, migration, and invasion of osteosarcoma cells in vitro, as well as tumour growth and pulmonary metastasis in vivo by targeting cadherin-2 (CDH2) and insulin-like growth factor 1 receptor (IGF-1R) [12] . In addition, it has been reported that miR-194 inhibited the EMT of EC cells [14] and gastric cancer cells [18] . MiR-194 has been identified as a prognostic marker of clear cell renal cell carcinoma (ccRCC) [19] , myelodysplastic syndromes (MDS) [20] , and HCC [15] . In addition to cancers, the biological functions of miR-194 in other diseases such as diabetes [21] and postmenopausal osteoporosis have also been investigated [22] . More recently, a study demonstrated that miR-194 was related with inflammatory response induced by palmitic acid (PA) [23] . In consideration of the above effects, we speculated that miR-194 might be involved in lung cell inflammatory response.
To confirm the hypothesis, the expression of miR-194 was first aberrantly expressed in human lung fibroblast WI38 cells by transfection with miR-194 mimic or inhibitor. After determining the high efficiency, we administrated LPS to the cells. LPS is a critical structural component of the outer membrane of Gram-negative bacteria, leading to systemic inflammatory response and nonspecific immune responses [24] . LPS is a widely used proinflammatory agent and is commonly accepted as a model of inducing pneumonia. The cell viability and the cell apoptosis were then measured after aberrant expression of miR-194 and administration of LPS. As expected, LPS significantly decreased the cell ability and increased the percentages of apoptotic cells compared to the control group, indicating a successful model for lung cell injury. Unlike the biological function of miR-194 in tumour cells, our study suggested that overexpression of miR-194 enhanced the cell viability and inhibited the cell apoptosis. But our study had similarities with those previous studies that miR-194 acted as a protective factor against diseases.
To further explore the underlying signalling pathway related to the effects of miR-194 aberrant expression on the cell viability and the cell apoptosis, we measured key proteins in NF-κB pathway including IκBα, p-65, and Bcl-3. Activation of the NF-κB signalling pathway plays a critical role in many different cell functions, such as inflammation, oncogenesis, cell apoptosis, and cell cycle progression [25] . Previous studies have demonstrated that LPS could induce the release of inflammatory cytokines and active NF-κB pathway [26] [27] [28] . IκBα, a crucial negative regulator of NF-κB activation, binds to NF-κB, which blocks it in the cytoplasm and inhibits DNA binding [29] . Bcl-3, one of novel or atypical IκB-like proteins, is also responsible for the activation of NF-κB pathway. However, the functional role of Bcl-3 in activation of NF-κB pathway is controversial. A few studies suggest that Bcl-3 participates in the removal of p50 and p52 homodimers from DNA and thus inhibits the transcriptional repressive effects of transcription activation domain (TAD) [30] [31] [32] . In contrast, other studies point that Bcl-3 interacts with p52 and p50, conferring upon them transcriptional activity [33] [34] [35] [36] . p65, a subunit of NF-κB, which is released from cytosolic IκBα and targeted to the nucleus after phosphorylation and ubiquitination of IκBα [37] . Our results revealed that LPS is capable of activating NF-κB pathway by inhibiting the expression of IκBα and upregulating the expression of p65 and Bcl-3. In contrast, overexpression of miR-194 reversed the effects of LPS on key proteins expressions, leading to inactivation of NF-κB pathway.
Conclusion
Our results suggest that miR-194 functions as a protective factor in LPS induced lung cell injury by increasing lung cell viability and inhibiting cell apoptosis. These effects might be achieved by inhibition of NF-κB pathway in WI38 cells. Additionally, miR-194 overexpression might be a potentially effective treatment of infantile pneumonia.
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